Jan 5 (Reuters) - Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna , filed for an initial public offering in the United States on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Pooja Desai)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
147.5 USD | -0.61% | -4.93% | +48.02% |
02:21pm | JPMorgan Raises Price Target on Moderna to $96 From $85 | MT |
01:09pm | Oppenheimer Raises Price Target on Moderna to $179 From $163 | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
147.5 USD | -0.61% | -4.93% | 56.87B | ||
27.82 EUR | +2.75% | -2.69% | 28.54B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.02% | 56.87B | |
+37.15% | 39.72B | |
-5.67% | 39.27B | |
-6.90% | 28.73B | |
+13.30% | 26.21B | |
-15.97% | 19.79B | |
+31.64% | 12.28B | |
+28.23% | 12.23B | |
+0.35% | 12.12B | |
-8.55% | 10.84B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna-backed genetic drugs firm Metagenomi files for US IPO